Share Price:

APNASPENAspen Pharmacare Hldgs19350-150 (-0.77%)

Aspen is in a closed period from 1st July 2024 until the publication of the FY2024 results on the JSE SENS platform to be released on the 3rd September 2024.

Aspen Trading Update

By : Shauneen Beukes

APN – Aspen Pharmacare Holdings Limited – Trading update
Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN & ISIN: ZAE000066692
(“Aspen”)

Trading update

Aspen shareholders are hereby advised that headline earnings per share, for the 12 months ended 30 June 2010, are expected to exceed those reported in the comparative period, ended 30 June 2009, by 20% to 25%. Earnings per share are anticipated to exceed those of the comparative period by 30% to 35%. The lower increase in headline earnings per share is caused by the exclusion of non-recurring capital profits and losses in the determination thereof. The Group’s South African business has been the leading contributor to the growth recorded.

The financial results on which this trading announcement is based have not been reviewed or reported on by Aspen`s external auditors.

Aspen`s results are scheduled to be published on SENS on 15 September 2010.

Woodmead
23 August 2010

Sponsor
Investec Bank Limited

Facebook
Twitter
LinkedIn
Pinterest

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.